Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION BP
| Report ID | 235098 |
| Drug Identification Number | 02462303 |
| Brand name | AMPICILLIN SODIUM FOR INJECTION BP |
| Common or Proper name | AMPICILLIN SODIUM FOR INJECTION BP |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | AMPICILLIN |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10ml x10 |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-08-12 |
| Estimated end date | Unknown |
| Actual end date | 2025-02-18 |
| Shortage status | Resolved |
| Updated date | 2025-02-19 |
| Company comments | Please be informed that AMPICILLIN SODIUM FOR INJECTION BP will be transferred to the Eugia label, DIN:02530473 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-02-19 | French | Compare |
| v4 | 2025-02-19 | English | Compare |
| v3 | 2024-08-13 | English | Compare |
| v2 | 2024-08-12 | French | Compare |
| v1 | 2024-08-12 | English | Compare |
Showing 1 to 5 of 5